Navigation Links
BD Announces Acquisition of Cytopeia
Date:5/13/2008

Expands Portfolio of Advanced Flow Cytometry Platforms

FRANKLIN LAKES, N.J., May 13 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has acquired all of the outstanding stock of Cytopeia, a privately held Washington corporation based in Seattle that develops and markets advanced flow cytometry cell sorting instruments.

Financial terms of this transaction were not disclosed. The acquisition is not expected to have a material impact on BD's fiscal year 2008 earnings.

"This strategic acquisition brings new technologies and capabilities that will enhance BD's ability to address growing customer needs in advanced applications, such as cell therapy research," said William A. Kozy, BD Executive Vice President. "This transaction reflects our commitment to bringing innovative tools to life scientists and will allow us to rapidly enter emerging areas of cell-based research."

Cytopeia's Influx(TM) cell sorter offers BD an open, configurable cell sorting platform that can be fully optimized for researchers' unique application-specific requirements. This high level of choice and control is particularly important for life science research on the leading edge of biomedical discovery. The Influx cell sorter is suited for a range of applications including cell therapy research, stem cell research, drug discovery and development, as well as marine biology. It complements the BD FACSAria(TM) II system -- the platform of choice in research labs around the world for a broad range of immunology cell sorting and multi-color applications.

Through the acquisition, BD gains the scientific leadership and insights of Dr. Ger van den Engh, a renowned innovator in flow cytometry.
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chindex International Announces Shelf Registration, Related Strategy and Guidance
2. Amicus Therapeutics Announces First Quarter 2008 Financial Results
3. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008
4. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
5. China Sky One Medical, Inc. Announces Record First Quarter 2008 Results
6. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
7. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
8. SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
9. Aton Pharma Announces Distribution Partnership in Brazil
10. China Medicine Announces Solid First Quarter 2008 Results
11. Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2009)... VEGA PROMOTIONAL SYSTEMS, INC. (Pink Sheets: VGPR...sed consulting firm, Tennessee Power Company, Inc....ction facility in Georgia. , , Vega recently ...n Georgia to take advantage of the abundance of bi... Georgia ranks third in the nation as a potential...
(Date:6/30/2009)... Microfluidics, a wholly owned sub... (OTC Bulletin Board: MFLU), and Particle Sciences...lp biopharmaceutical companies leverage the most a...n methods available to develop, analyze and commer..., , Particle Sciences is a leading Contract Res...
(Date:6/30/2009)...Call/ -- Novavax, Inc. (Nasdaq: NVAX ) announced...etary, recombinant virus-like-particle (VLP) vacci...I) of Spain. ROVI will use the VLP technology to ...for the Spanish government under a new 60 million-...stry of Health and other government groups to deve...
(Date:6/30/2009)...e Taichung Harbor to Xiamen , China and carri...ITY OF INDUSTRY, Calif. and HONG KONG, June 30 /PR...(Pink Sheets: EFTB) announced today that the Compa...rporation, completed its inaugural passenger voyag...voyage across the Taiwan Strait takes only 4 1/2 h...
Breaking Biology Technology:Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 2Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 3Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 4Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain 5EFT BioTech Holdings, Inc.'s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 2EFT BioTech Holdings, Inc.'s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 3
...ion Kit , , Mammalian who... for molecular assays due to abundant genetic i...d simplicity of sample collection. RNA , ...g, but Ambions , MagMAX-96 Bloo... lysis conditions and proteases to ef...
...Byrom, Ambion, Inc., More , ...xperiments to , elucidate cellu..., effect is only evaluated at the...oach overlooks the true subject of most siRNA stud...used by a reduction in the target protein. , ...
...d Brown (Senior Scientist, , A...on that RNA interference (RNAi) , ...e function , studies occurred w... publication describing the use of small int...malian cells in 2001. In less than two years, , ...
...ropriate storage of cells or tissue , ...for preservation of , intact RN..., solution designed specifically...ring storage of fresh tissue and cell samples. Her...stions regarding <A , href="htt...
Other Biology Technology:Robust High Throughput RNA Isolation from Blood Samples 2Robust High Throughput RNA Isolation from Blood Samples 3Robust High Throughput RNA Isolation from Blood Samples 4RNAi: Get the Whole Story 2RNAi: Get the Whole Story 3RNAi: Get the Whole Story 4RNAi: Get the Whole Story 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 2RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 3RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 4RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 6RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 7RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 8RNAlater FAQs: Preserving RNA Before Isolation 2RNAlater FAQs: Preserving RNA Before Isolation 3RNAlater FAQs: Preserving RNA Before Isolation 4
(Date:7/2/2009)...IA KEY, Fla. As the nation celebrates its birth o...sor Diego Lirman and fellow Caribbean coral reef n...e National Oceanic and Atmospheric Administration ... and its partners, staghorn and elkhorn coral reco...ne National Park, will receive support from the Am...
(Date:7/1/2009)...1 July, 2009 Johnson & Johnson today announced th... of Molecular Biology at the Max Planck Institute ... led to novel cancer therapies including Herceptin...l Janssen Award for Biomedical Research. An indep...cted Dr. Ullrich, who on September 8 will receive ...
(Date:7/1/2009)...ansen,s work on the formation of the centromere, a...g chromosome segregation and accurate cell divisio...logy and a prestigious EMBO installation grant, o...s. , Lars Jansen moved from California to the In...ast year to head the Epigenetic Mechanisms group. ...
(Date:7/1/2009)...ts and undergraduate students from across the Unit...nth-long field course in the Russian Arctic. The p...future leaders in arctic research and education, a...te change. , Dr. R. Max Holmes, an associate s...ector of the Polaris Project, says, "The Arctic is...
Breaking Biology News(10 mins):Nursery programs for corals receive TLC from NOAA this Independence Day 2Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Double success for Instituto Gulbenkian de Ciencia scientists working on chromosome segregation 2International team of students and scientists on month-long field course in Siberian Arctic 2International team of students and scientists on month-long field course in Siberian Arctic 3UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets 10511 1UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets 10511 2UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets 10511 3Jefferson neurosurgeons using new liquid treatment for wide neck brain aneurysm 10509 1Jefferson neurosurgeons using new liquid treatment for wide neck brain aneurysm 10509 2Jefferson neurosurgeons using new liquid treatment for wide neck brain aneurysm 10509 3Examination by National Expert Shows Blue Cross Blue Shield of Michigans Social Mission Contributions Totaled at Least 24391 Million in 2007 10507 1Examination by National Expert Shows Blue Cross Blue Shield of Michigans Social Mission Contributions Totaled at Least 24391 Million in 2007 10507 2Examination by National Expert Shows Blue Cross Blue Shield of Michigans Social Mission Contributions Totaled at Least 24391 Million in 2007 10507 3Deep Brain Stimulation May Improve Recall 10505 1Deep Brain Stimulation May Improve Recall 10505 2
... and bioMerieux announced today that Affymetrix ha...ccess to its GeneChip(R) technology to develop and...r, as well as an option to expand the agreement in... the Powered by Affymetrix(TM) program, gives bioM...d arrays, instrumentation systems and future impro...
... clear, especially when it comes to the vaccine de...end if you want to understand what the vaccine is ...d Kingdom, February 16, 2005 -- The European Vacci...phase I clinical trial of novel investigational va...e prevention of HIV infection has started in Lausa...
...nant evolutionary paradigm, Luiz Rocha and colleag...te, Harvard University the University of Florida a...h from neighboring habitats may differ more from o... An ecological speciation model for coral reef org...c treatment of speciation on land and sea. , Coral...
...e mouth and throat, surgery is a frequent course o...g dysfunction and external scarring. Researchers f...ine,s Department of Otorhinolaryngology/Head and N...comprehensive and largest to date ?that demonstrat...c System to perform Trans-Oral Robotic Surgery (TO...
Other Biology News:'EuroVacc 02' HIV Vaccine Trial Begins 2'EuroVacc 02' HIV Vaccine Trial Begins 3An (ecological) origin of species for tropical reef fish 2Penn Researchers Use Robotic Surgery 2Penn Researchers Use Robotic Surgery 3
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins.
Recombinant Mouse LIGHT/TNFSF14
Request Info
BL21 Star strains are high-performance BL21 hosts designed for improved protein yield in T7 promoter-based expression systems (Figure 1). Because the T7 RNA polymerase synthesizes mRNA more rapidly t
Biology Products: